...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >ROLE OF PHARMACISTS IN REDUCING DRUG-RELATED PROBLEMS IN HEMODIALYSIS OUTPATIENTS
【24h】

ROLE OF PHARMACISTS IN REDUCING DRUG-RELATED PROBLEMS IN HEMODIALYSIS OUTPATIENTS

机译:药剂师在减少血液透析病患者药物相关问题中的作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objectives: Hemodialysis outpatients have a higher risk of developing drug-related problems. Pharmacists play a key role in identifying and preventing these drug-related problems. This study aimed to assess the effect of pharmacist intervention on the number and types of drug-related problems in outpatients undergoing hemodialysis at Indonesia Christian University Hospital. Methods: This pre- and post-prospective study was conducted from January 2013 to June 2013. We evaluated 86 patients who were prescribed 804 drugs. Results: A total of 337 drug-related problems were identified (41.86% of the total drugs prescribed). The types of drug-related problems identified were as follows: Failed therapy (18.69%); sub-optimal therapy (52.23%); indication of non-administration of therapy (2.37%); and non-allergic adverse drug effects (26.71%). The physicians received 59 recommendations, and the patients received 278 recommendations. These recommendations resulted in a decrease in ineffective drug therapy or therapeutic failure (18.69-0%), sub-optimal therapy (52.23-21.36%), indications of non-administration of drug (2.37-2.08%), and non-allergic adverse drug effects (26.71-9.20%). The factors that significantly affected the occurrence of drug-related problems were hemodialysis frequency, number of comorbidities, and number of drugs prescribed. Patients undergoing hemodialysis 3 times a week were more likely to experience a decrease in drug-related problems than those undergoing hemodialysis twice a week (odds ratio 26.33, 95% confidence interval 2.710-255.884). Conclusions: Pharmacist intervention could decrease drug-related problems in hemodialysis patients.
机译:目的:血液透析门诊患者出现药物相关问题的风险较高。药剂师在识别和预防这些与药物有关的问题中起着关键作用。这项研究旨在评估在印度尼西亚基督教大学医院进行血液透析的门诊患者中,药剂师干预对药物相关问题的数量和类型的影响。方法:这项前瞻性和后瞻性研究于2013年1月至2013年6月进行。我们评估了86例处方804种药物的患者。结果:共发现337个与药物有关的问题(占处方药总数的41.86%)。查明与毒品有关的问题的类型如下:治疗失败(18.69%);次优疗法(52.23%);不治疗的迹象(2.37%);和非过敏性药物不良反应(26.71%)。医师收到59条建议,患者收到278条建议。这些建议导致无效的药物治疗或治疗失败的减少(18.69-0%),次优治疗(52.23-21.36%),未给药的适应症(2.37-2.08%)和非过敏性不良反应的减少药物作用(26.71-9.20%)。严重影响药物相关问题发生的因素是血液透析频率,合并症数和处方药数。每周进行3次血液透析的患者比每周进行两次血液透析的患者更有可能减少与药物相关的问题(优势比26.33,95%置信区间2.710-255.884)。结论:药剂师的干预可以减少血液透析患者的药物相关问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号